Dr. Reddy's Laboratories Limited (DRREDDY.BO)

INR 1323.15

(3.77%)

Annual Cash Flows

(In INR)
Breakdown 2024 2023 2022 2021 2020 2019
Operating Cash Flow 44.96 Billion 58.87 Billion 28.1 Billion 35.7 Billion 29.84 Billion 28.7 Billion
Net Income 55.68 Billion 60.48 Billion 23.56 Billion 19.14 Billion 19.49 Billion 18.79 Billion
Depreciation & Amortization 14.85 Billion 12.5 Billion 11.82 Billion 12.79 Billion 12.47 Billion 12.19 Billion
Deferred income taxes 16.18 Billion 15.3 Billion 8.73 Billion 9.17 Billion -1.46 Billion 3.64 Billion
Stock-based compensation 407 Million 397 Million 592 Million 584 Million 521 Million 389 Million
Change in working capital -20.18 Billion -7.85 Billion -13.91 Billion -8.28 Billion -7.53 Billion -5.77 Billion
Other non-cash items 47.35 Billion -21.95 Billion -2.69 Billion 2.28 Billion 6.35 Billion -547 Million
Investing Cash Flow -42.06 Billion -41.37 Billion -26.38 Billion -22.66 Billion -4.92 Billion -7.72 Billion
Investments in PPE -27.43 Billion -18.86 Billion -19.04 Billion -12.56 Billion -6.11 Billion -7.49 Billion
Acquisitions 1.06 Billion 23.36 Billion -326 Million -15.51 Billion 214 Million 536 Million
Investment purchases -145.5 Billion -136.17 Billion -88.97 Billion -75.41 Billion -111.91 Billion -78.57 Billion
Sales/Maturities of investments 129.78 Billion 112.8 Billion 77.77 Billion 79.52 Billion 111.7 Billion 76.29 Billion
Other Investing Activities 21 Million -22.5 Billion 4.18 Billion 1.3 Billion 1.19 Billion 1.51 Billion
Financing Cash Flow -1.49 Billion -26.86 Billion -2.42 Billion -298 Million -25.15 Billion -21.32 Billion
Debt repayment -5.49 Billion -1.01 Billion -785 Million -4.49 Billion -23.4 Billion -15.18 Billion
Dividends payments -6.64 Billion -4.97 Billion -4.14 Billion -4.14 Billion -3.91 Billion -4 Billion
Common Stock Repurchased - - - -1.19 Billion -474 Million -535 Million
Common Stock Issuance 805 Million 368 Million 334 Million 269 Million 4 Million 15.18 Billion
Other Financing Activities 4.03 Billion -20.86 Billion 2.5 Billion 9.27 Billion 2.62 Billion -16.78 Billion
Accounts receivables -8.05 Billion -5.75 Billion -17.01 Billion 2.08 Billion -12.44 Billion 1.79 Billion
Accounts payables 3.46 Billion 23 Million 4.41 Billion 2.86 Billion 1.57 Billion 398 Million
Inventory -18.44 Billion -2.65 Billion -5.32 Billion -9.88 Billion -1.48 Billion -8.49 Billion
Other working capital 2.85 Billion 528 Million 4.01 Billion -3.34 Billion 4.82 Billion 530 Million
Cash at beginning of period 5.77 Billion 14.85 Billion 14.82 Billion 1.96 Billion 2.22 Billion 2.54 Billion
Cash at end of period 7.1 Billion 5.77 Billion 14.85 Billion 14.82 Billion 1.96 Billion 2.22 Billion
Capital Expenditure -27.43 Billion -18.86 Billion -19.04 Billion -12.56 Billion -6.11 Billion -7.49 Billion
Effect of forex changes on cash -59 Million 286 Million 733 Million 113 Million -25 Million 35 Million
Net cash flow / Change in cash 1.32 Billion -9.07 Billion 32 Million 12.85 Billion -266 Million -314 Million
Free Cash Flow 17.53 Billion 40 Billion 9.05 Billion 23.14 Billion 23.72 Billion 21.21 Billion

Cash Flow Charts